Shields Michael D, ALQahtani Fahad, Rivey Michael P, McElnay James C
Centre for Infection and Immunity. School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, United Kingdom.
Clinical and Practice Research Group, School of Pharmacy, Queen's University of Belfast, Belfast, United Kingdom.
PLoS One. 2018 Feb 5;13(2):e0190031. doi: 10.1371/journal.pone.0190031. eCollection 2018.
We describe, for the first time, the use of a mobile device platform for remote direct observation of inhaler use and technique. The research programme commenced with a rapid systematic review of mobile device (or videophone) use for direct observation of therapy (MDOT). Ten studies (mainly pilots) were identified involving patients with tuberculosis, sickle cell disease and Alzheimer's disease. New studies are ongoing (ClinicalTrials.gov website) in TB, stroke, sickle cell disease, HIV and opioid dependence. Having identified no prior use of MDOT in inhaler monitoring, we implemented a feasibility study in 12 healthy volunteer children (2-12 years; 8 females and 4 males) over a period of 14 days, with twice daily video upload of their 'dummy' inhaler use. Two children uploaded 100% of the requested videos, with only one child having an inhaler upload rate of <75%. The quality of uploaded videos was generally good (only 1.7% of unacceptable quality for evaluation). The final aspect of the research was a pilot study using MDOT (6 weeks) in 22 children with difficult to treat asthma. Healthcare professionals evaluated inhaler technique using uploaded videos and provided telephone instruction on improving inhaler use. The main outcomes were assessed at week 12 post initiation of MDOT. By week 5, all children still engaging in MDOT (n = 18) were judged to have effective inhaler technique. Spirometry values did not vary to a significantly significant degree between baseline and 12 weeks (P>0.05), however, mean fraction of exhaled nitric oxide (FeNO) values normalised (mean 38.7 to 19.3ppm) and mean Asthma Control Test values improved (13.1 to mean 17.8). Feedback from participants was positive. Overall the findings open up a new paradigm in device independent (can be used for any type of inhaler device) monitoring, providing a platform for evaluating / improving inhaler use at home.
我们首次描述了使用移动设备平台对吸入器使用情况和技术进行远程直接观察。该研究项目始于对用于直接观察治疗的移动设备(或可视电话)(MDOT)的快速系统评价。确定了十项研究(主要是试点研究),涉及肺结核、镰状细胞病和阿尔茨海默病患者。目前正在针对肺结核、中风、镰状细胞病、艾滋病毒和阿片类药物依赖开展新的研究(ClinicalTrials.gov网站)。由于此前未发现MDOT用于吸入器监测的情况,我们对12名健康志愿者儿童(2至12岁;8名女性和4名男性)进行了为期14天的可行性研究,要求他们每天两次上传使用“模拟”吸入器的视频。两名儿童上传了100%要求的视频,只有一名儿童的吸入器上传率低于75%。上传视频的质量总体良好(只有1.7%的视频质量不可接受,无法用于评估)。该研究的最后一个方面是对22名难治性哮喘儿童进行为期6周的MDOT试点研究。医疗保健专业人员通过上传的视频评估吸入器技术,并提供关于改善吸入器使用的电话指导。主要结果在MDOT开始后的第12周进行评估。到第5周时,所有仍在参与MDOT的儿童(n = 18)被判定吸入器技术有效。肺功能测定值在基线和12周之间没有显著变化(P>0.05),然而,呼出一氧化氮平均分数(FeNO)值恢复正常(平均从38.7降至19.3ppm),哮喘控制测试平均分值有所改善(从13.1提高到平均17.8)。参与者的反馈是积极的。总体而言,这些发现开创了一种独立于设备(可用于任何类型的吸入器设备)监测的新范式,为在家中评估/改善吸入器使用提供了一个平台。